Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Oct 30, 2026
TickeronGET DAILY SIGNALS
Altria Group (MO) Eyes +11% Move Toward $85 After Q3 Results

Altria Group (MO) Eyes +11% Move Toward $85 After Q3 Results

Key Takeaways

  • The $85 level serves as a technical and psychological target above the 52-week high rather than an analyst consensus figure.
  • Average analyst price targets hover near $70, below the recent share price, so the $85 milestone acts as a fallback objective.
  • With the stock closing near $76.75, reaching $85 would require a gain of roughly 11%.
  • Analyst targets range widely from about $58 to $83, highlighting disagreement on the sustainability of Altria's earnings growth.
  • Positive drivers include raised 2026 guidance, a 61st consecutive dividend increase, an expanded buyback, and on! pouch volume growth; risks center on cigarette-volume declines, oral tobacco softness, and regulatory pressures.

Why Analyst Targets Fall Short of $85

The $85 objective comes from a fallback method because standard analyst consensus does not support it here. Aggregators show average price targets around $69.90 to $70.55, which sit below the recent price near $76.75, and even the highest targets barely clear that level. With the mean of valid targets below the current price and no meaningful premium above it, the analyst average cannot serve as a usable benchmark for this exercise.

Individual targets stretch from roughly $58 to $83. UBS lifted its target to $83 from $79 after the earnings release and kept a Buy rating, while Barclays and Citigroup remain more cautious with targets near $63 and $65. Morgan Stanley holds an Equal Weight stance with a target around $71. The spread reflects differing views: some analysts focus on earnings stability and moderating cigarette declines, while others highlight premium-share erosion and the challenge of valuing a business facing long-term contraction.

Current Position and the Path to $85

The stock recently closed near $76.75, just under its 52-week high of about $77, after rising roughly 5% on the quarterly results. Reaching $85 from here would mean an additional gain of about 11%, a sizable move for a mature consumer staples name with low single-digit earnings growth expectations.

A realistic route to $85 would likely require a clear breakout and sustained hold above the prior 52-week high, moving the shares into multi-year high territory, plus continued upward revisions to earnings estimates as confidence grows in the smoke-free transition and pricing power. Such a move would probably also call for multiple expansion on the current mid-teens price-to-earnings ratio.

Supportive Factors in Play

Altria posted third-quarter adjusted diluted EPS of $1.52, up 4.8% from a year earlier and ahead of estimates, then raised full-year 2026 adjusted EPS guidance to $5.66–$5.74, pointing to 4.5%–6% growth. Smokeable products benefited from solid pricing, with Marlboro retaining 60% of the premium cigarette segment. The on! nicotine pouch brand saw shipment volume rise 13.3% year over year. The company raised its quarterly dividend 4.7% to $1.11 per share, added $1 billion to its repurchase authorization, and saw stronger equity earnings from its Anheuser-Busch InBev stake.

Key Risks That Could Cap Gains

The main headwind remains the structural drop in cigarette consumption, with domestic shipment volume down 2.9% in the quarter. Pricing power in smokeables has moderated, and some consumers are shifting to discount brands amid economic pressures. Oral tobacco results were softer, with adjusted operating income falling 3.7% as Copenhagen and Skoal volumes declined sharply and on! lost share in the growing nicotine pouch category. Regulatory risks stay elevated, including litigation and FDA review of vapor products, while illicit e-vapor products continue to affect the legal market.

Technical Levels to Watch

The shares are testing the upper end of the 52-week range, with the prior high near $77 serving as near-term resistance. A sustained move above that level would open room toward the next psychological mark at $85. On the downside, the breakout zone around $73–$74 and the broader $68–$70 area, near the average analyst target, stand out as important support zones. The longer-term trend has strengthened after the climb from the 52-week low near $54.70.

Time Horizon and Items to Monitor

Analyst targets generally look out about 12 months. I am watching the next earnings report closely for signs that cigarette-volume declines are stabilizing and that on! is translating shipments into lasting consumer demand. Also relevant are any FDA or regulatory decisions on vapor products, updates to the dividend and buyback plans, and further analyst target changes after the guidance lift. Interest-rate conditions matter for this income-focused name, as lower yields often support demand for high-dividend equities.

Using AI Daily Buy/Sell Signals

I also checked this using Tickeron’s AI Daily Buy/Sell Signals to see how the stock compares to others in the industry. In my view, the tool offers a practical way to track technical shifts and generate data-driven signals alongside fundamental work. For investors following Altria’s potential breakout, it provides a concise complement to earnings reviews and analyst notes without replacing them.

Final Assessment

The $85 target for Altria Group remains a technical and psychological benchmark rather than an analyst consensus, underscoring how far the stock has already advanced. Achieving it would require an additional gain of roughly 11% from current levels—a notable move that would likely hinge on a durable breakout above the 52-week high and sustained confidence in the smoke-free transition. Support comes from raised guidance, steady dividend growth, buybacks, and on! momentum, while the main obstacles are secular volume decline, oral tobacco weakness, and regulatory uncertainty. The broad analyst range shows there is no clear agreement on further upside, and no outcome is assured.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MO

MO's RSI Oscillator recovers from overbought zone

The 10-day RSI Indicator for MO moved out of overbought territory on November 02, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 instances where the indicator moved out of the overbought zone. In 23 of the 44 cases the stock moved lower in the days that followed. This puts the odds of a move down at 52%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MO as a result. In 31 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 38%.

The Moving Average Convergence Divergence Histogram (MACD) for MO turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 22 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 47%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 35%.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +1.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where MO advanced for three days, in 225 of 390 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.

MO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 127 of 291 cases where MO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 44%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.

The Tickeron Valuation Rating of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MO's P/B Ratio (-47.639) is very low in comparison to the industry average of (-7.297). P/E Ratio (16.025) is within average values for comparable stocks, (12.512). Projected Growth (PEG Ratio) (2.649) is also within normal values, averaging (3.595). Dividend Yield (0.058) settles around the average of (0.060) among similar stocks. MO's P/S Ratio (5.744) is slightly higher than the industry average of (2.780).

The Tickeron SMR rating for this company is 8 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 29 (best 1 - 100 worst), indicating outstanding price growth. MO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

Notable companies

The most notable companies in this group are Philip Morris International (NYSE:PM), Altria Group (NYSE:MO).

Industry description

The industry is engaged in the growth, preparation for sale, advertisement, and distribution of tobacco and tobacco-related products like cigarettes. In 2017, tobacco companies spent an estimated $9.36 billion marketing cigarettes and smokeless tobacco in the U.S. – an amount that translates to more than $25 million each day (according to a CDC report). Philip Morris International Inc., Altria Group Inc., and British American Tobacco plc are some major cigar makers. In recent times, vaping or the use of e-cigarette (does not burn tobacco) is gaining momentum – several established cigarette makers are trying to expand their footprint in this new market.

Market Cap

The average market capitalization across the Tobacco Industry is 57.21B. The market cap for tickers in the group ranges from 99 to 308.42B. PM holds the highest valuation in this group at 308.42B. The lowest valued company is AHII at 99.

High and low price notable news

The average weekly price growth across all stocks in the Tobacco Industry was -19%. For the same Industry, the average monthly price growth was -24%, and the average quarterly price growth was -35%. MO experienced the highest price growth at -5%, while XXII experienced the biggest fall at -56%.

Volume

The average weekly volume growth across all stocks in the Tobacco Industry was 90%. For the same stocks of the Industry, the average monthly volume growth was 50% and the average quarterly volume growth was 85%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 40
P/E Growth Rating: 52
Price Growth Rating: 70
SMR Rating: 73
Profit Risk Rating: 71
Seasonality Score: 35 (-100 ... +100)
AI Patterns 1
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a holding company which produces and markets tobacco products

Industry Tobacco

Industry
Tobacco
Address
6601 West Broad Street
Phone
+1 804 274-2200
Employees
5900
Web
https://www.altria.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.